| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | -2.14% | -0.94% | -1.20% | -1.20% | — |
| 14d | 1 | +100.00% | -7.62% | -3.54% | -4.08% | -4.08% | — |
| 30d | 1 | +100.00% | -0.71% | +0.40% | -1.12% | -1.12% | — |
| 60d | 1 | +0.00% | +2.86% | +8.93% | -6.07% | -6.07% | — |
| 90d | 1 | +100.00% | -6.43% | +8.90% | -15.33% | -15.33% | — |
| 180d | 1(1 pending) | — | — | — | — | — | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| AQST AQUESTIVE THERAPEUTICS, INC. | SALE Chief Financial Officer | 92,652 | $4.18 | $387.3K | 283,460 | May 5, 2026 | May 7, 2026 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | SALE Chief Financial Officer | 58,254 | $4.17 | $243.1K | 376,112 | Mar 10, 2026 | Mar 11, 2026 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 70,000 | — | — | 70,000 | Mar 9, 2026 | Mar 11, 2026 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 95,000 | — | — | 434,366 | Mar 9, 2026 | Mar 11, 2026 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | SALE Chief Financial Officer | 8,736 | $2.65 | $23.2K | 339,366 | Mar 9, 2025 | Mar 11, 2025 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 110,000 | — | — | 358,295 | Mar 7, 2025 | Mar 11, 2025 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 60,000 | Mar 7, 2025 | Mar 11, 2025 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 82,500 | — | — | 82,500 | Mar 7, 2025 | Apr 13, 2026 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | SALE Chief Financial Officer | 10,193 | $2.65 | $27.0K | 348,102 | Mar 7, 2025 | Mar 11, 2025 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | SALE SVP, Chief Financial Officer | 11,705 | $4.88 | $57.1K | 248,295 | Mar 9, 2024 | Mar 12, 2024 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 120,000 | — | — | 260,000 | Mar 7, 2024 | Mar 11, 2024 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 60,000 | Mar 7, 2024 | Mar 11, 2024 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 70,000 | — | — | 70,000 | Aug 9, 2023 | Aug 9, 2023 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 70,000 | — | — | 70,000 | May 5, 2023 | May 9, 2023 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 140,000 | — | — | 140,000 | Mar 9, 2023 | Mar 9, 2023 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Nov 4, 2022 | Nov 8, 2022 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 70,000 | — | — | 70,000 | Mar 10, 2022 | Mar 14, 2022 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 120,000 | — | — | 120,000 | Jun 15, 2021 | Jun 17, 2021 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 2,500 | — | — | 2,500 | Mar 11, 2021 | Mar 15, 2021 ↗ | View → |